| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 12/02/2009 | CN101595119A Crystalline forms of 11 beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17- hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one |
| 12/02/2009 | CN101590066A Medicinal application of 1,6-diphosphate fructose in treating epilepsy complication and preventing epilepsy |
| 12/02/2009 | CN101590063A Application of tanshinone IIA in preparing medicament for treating obesity and insulin resistance |
| 12/02/2009 | CN101590011A Sustained release of peptides from pharmaceutical compositions |
| 12/02/2009 | CN100564378C Pyrrolidine oxadiazole- and thiadiazole derivatives |
| 12/01/2009 | US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |
| 12/01/2009 | US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 12/01/2009 | US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes |
| 12/01/2009 | CA2407210C Liposome drug delivery |
| 11/26/2009 | WO2009140763A1 Novel ghrelin analogues |
| 11/26/2009 | US20090291953 Pharmaceutical salts of reboxetine |
| 11/26/2009 | US20090291924 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof |
| 11/26/2009 | CA2724976A1 Novel ghrelin analogues |
| 11/25/2009 | EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses |
| 11/25/2009 | EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use |
| 11/25/2009 | EP2123652A1 Heterocyclic compound |
| 11/25/2009 | EP2123279A1 Sequential application of 20,20,21,21,21-Pentafluor-17-hydroxy-1 1beta-[4-(hydroxyacetyl) phenyl]-19-nor-17alpha-pregna-4,9-dien-3-on and one or more gestagens for treating gynaecological illnesses |
| 11/25/2009 | EP2121758A1 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 11/25/2009 | EP2121723A2 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
| 11/25/2009 | CN101588804A Method for treating or preventing symptoms of hormonal variations |
| 11/25/2009 | CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 11/25/2009 | CN101585779A New crystal form of Agomelatine, preparation method and use thereof |
| 11/25/2009 | CN101584807A Application of traditional Chinese medicine composition in preparing medicament of insulin sensitizer |
| 11/24/2009 | CA2445678C Paroxetine controlled release compositions |
| 11/24/2009 | CA2431355C 14.beta., 16,17-methylene steroids as novel androgens |
| 11/24/2009 | CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/24/2009 | CA2403831C Coating and binding agent for pharmaceutical formulations having improved storage stability |
| 11/24/2009 | CA2385882C Tyrosine derivatives |
| 11/24/2009 | CA2338342C Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 11/24/2009 | CA2201105C Inhibitor of stem cell proliferation and uses thereof |
| 11/19/2009 | WO2009140448A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 11/19/2009 | WO2009140126A1 Method of administering a therapeutic |
| 11/19/2009 | WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 11/19/2009 | WO2009139340A1 Pyrazole compound |
| 11/19/2009 | US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent |
| 11/19/2009 | US20090286735 Method for administering glp-1 molecules |
| 11/19/2009 | US20090285816 Albumin Fusion Proteins |
| 11/19/2009 | US20090285752 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| 11/19/2009 | CA2724629A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 11/19/2009 | CA2724332A1 Method of treatment |
| 11/19/2009 | CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group |
| 11/19/2009 | CA2724030A1 Sequential administration of 20,20,21,21-pentafluoro-17-hydroxy-11.beta.-[4-(hydroxyacetyl) phenyl]-19-nor-17.alpha.-pregna-4,9-diene-3-one and one or more progestational hormonesfor treating gynaecological diseases |
| 11/18/2009 | EP2119785A1 Novel peptides |
| 11/18/2009 | EP2119719A1 Thiazepine derivative |
| 11/18/2009 | EP2119441A1 Use of angiotensin II receptor antagonists in order to increase insulin sensitivity |
| 11/18/2009 | EP2119438A1 Bone metabolism ameliorating agent |
| 11/18/2009 | EP2118120A1 Nitric oxide releasing steroids |
| 11/18/2009 | CN101583598A Novel indole derivative having inhibitory activity on i kappa b kinase ss |
| 11/18/2009 | CN101583349A Sugar coatings and methods therefor |
| 11/18/2009 | CN101579407A Method for preparing animal models with low serum melatonin level by using acidoid |
| 11/18/2009 | CN100560132C Contraception process and administration for same |
| 11/18/2009 | CN100560074C External patch containing estrogen and/or progestogen |
| 11/17/2009 | US7619001 Utilization of dialkylfumarates |
| 11/17/2009 | US7618963 Bicyclic heteroaromatic compounds |
| 11/17/2009 | US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 11/17/2009 | CA2402524C Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate |
| 11/17/2009 | CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 11/17/2009 | CA2374158C Indole derivatives |
| 11/17/2009 | CA2369997C Compositions and methods for treating amyloidosis |
| 11/12/2009 | WO2009137534A2 Estrogenic extracts for use in treating vaginal and vulvar atrophy |
| 11/12/2009 | WO2009137334A2 Method for treating neurodegenerative dysfunction |
| 11/12/2009 | WO2009137080A1 Compositions of gnrh related compounds and processes of preparation |
| 11/12/2009 | WO2009136629A1 Prophylactic/therapeutic agent for lifestyle-related diseases |
| 11/12/2009 | WO2009135651A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2 |
| 11/12/2009 | WO2009135449A1 LIGANDS OF ESTROGEN RECEPTORS α AND β, METHOD OF THEIR PREPARATION AND PHARMACEUTICALS COMPRISING THEM |
| 11/12/2009 | WO2009117378A3 Therapeutic amides |
| 11/12/2009 | US20090281096 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 11/12/2009 | US20090280192 Method for treating or preventing alzheimer's disease |
| 11/12/2009 | US20090280170 Compositions of GnRH related compounds and processes of preparation |
| 11/12/2009 | CA2723688A1 Method for treating neurodegenerative dysfunction |
| 11/12/2009 | CA2723558A1 Compositions of gnrh related compounds and processes of preparation |
| 11/12/2009 | CA2723545A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2 |
| 11/12/2009 | CA2723403A1 Estrogenic extracts for use in treating vaginal and vulvar atrophy |
| 11/11/2009 | EP2116264A1 Preparation for transnasal application |
| 11/11/2009 | EP2116250A1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 11/11/2009 | EP2114239A1 Model predictive method and system for controlling and supervising insulin infusion |
| 11/11/2009 | EP1884240B1 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 11/11/2009 | EP1863464B1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 11/11/2009 | EP1709023B1 Selective estrogen receptor modulators |
| 11/11/2009 | EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone |
| 11/11/2009 | EP1317286B1 Administration form for hormonal contraception |
| 11/11/2009 | CN101574409A Method of using bitter cold traditional Chinese medicine to construct animal modes with continuous low level of serum melatonin |
| 11/11/2009 | CN101574360A Application of epimedin in preparing medicines for treating diseases where estrogen needs supplementing |
| 11/11/2009 | CN101574338A Pharmaceutical composition for restraining activity of aromatizing enzyme and application thereof |
| 11/11/2009 | CN101574084A 螺二氢吲哚哌啶衍生物 Spiroindoline piperidine derivative |
| 11/11/2009 | CN100558899C Growth hormone fusion protein |
| 11/11/2009 | CN100558741C 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 11/11/2009 | CN100558717C Novel medicine |
| 11/11/2009 | CN100558712C Therapeutic molecules and methods-1 |
| 11/11/2009 | CN100558698C Calcium receptor-active compounds |
| 11/10/2009 | US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation |
| 11/10/2009 | US7615532 Insulin derivatives |
| 11/10/2009 | CA2419887C Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |
| 11/10/2009 | CA2378792C Aminothiazole derivatives and their use as crf receptor ligands |
| 11/05/2009 | WO2009134204A1 RESTORATION OF ESTROGEN RECEPTOR-α ACTIVITY |
| 11/05/2009 | WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same |
| 11/05/2009 | WO2009133861A1 Cyclic amine compound |
| 11/05/2009 | US20090275541 Method for treating neurocognitive dysfunction |
| 11/05/2009 | US20090275501 Somatostatin-dopamine chimeric analogs |
| 11/05/2009 | CA2722854A1 Restoration of estrogen receptor-.alpha. activity |